日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer

在大样本经手术分期的非子宫内膜样(II型)子宫内膜癌患者队列中,HER2基因扩增和EGFR表达情况

Konecny, G E; Santos, L; Winterhoff, B; Hatmal, M; Keeney, G L; Mariani, A; Jones, M; Neuper, C; Thomas, B; Muderspach, L; Riehle, D; Wang, H-J; Dowdy, S; Podratz, K C; Press, M F

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells.

拉帕替尼(一种新型 HER2 和 EGFR 双激酶抑制剂)在人子宫内膜癌细胞中的活性

Konecny G E, Venkatesan N, Yang G, Dering J, Ginther C, Finn R, Rahmeh M, Fejzo M Schoenberg, Toft D, Jiang S-W, Slamon D J, Podratz K C